Provided by Tiger Trade Technology Pte. Ltd.

Alnylam Pharmaceuticals

236.22
+6.923.02%
Post-market: 236.480.2586+0.11%19:58 EDT
Volume:1.91M
Turnover:449.27M
Market Cap:31.52B
PE:42.04
High:238.97
Open:228.88
Low:228.34
Close:229.30
52wk High:495.55
52wk Low:197.81
Shares:133.43M
Float Shares:133.16M
Volume Ratio:1.16
T/O Rate:1.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.62
EPS(LYR):2.33
ROE:96.55%
ROA:12.34%
PB:23.28
PE(LYR):101.38

Loading ...

Lumentum, Applied Materials, Corning, Astrazeneca, and More Stocks That Explain Today's Market

Dow Jones
·
Jul 09

Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Eli Lilly & Co (LLY)

TIPRANKS
·
Jul 09

Alnylam Pharmaceuticals up over 12%, on Pace for Largest Percent Increase Since July 2025

Dow Jones
·
Jul 09

Movement Alert|Alnylam Pharmaceuticals Rises 15.34% in Regular Trading, Competitor AstraZeneca Late-Stage Cardiac Trial Failure Clears Competitive Path

Market Focus
·
Jul 09

Alnylam Pharmaceuticals Shares Jump 15.5% After Astrazeneca's Nerve Disease Drug Wainua Fails Late-stage Heart Disease Trial

THOMSON REUTERS
·
Jul 09

S&P 500 Futures Climb in Premarket Trading; Alnylam Pharmaceuticals, Bridgebio Pharma Lead

Dow Jones
·
Jul 09

Premarket Movers | ALNY Jumps Nearly 16% as Rival Drug Wainua Flops Critical Trial

Tiger Newspress
·
Jul 09

Bridgebio Pharma Shares Rise 9.9%

THOMSON REUTERS
·
Jul 09

Movement Alert|Alnylam Pharmaceuticals Rises 6.11% in Pre-Market Trading, Trading at $336.95

Market Focus
·
Jul 09

Movement Alert|Alnylam Pharmaceuticals Rises 5.1% Overnight, Trading at $340.0

Market Focus
·
Jul 09

Astrazeneca's Wainua Fails Key Heart Disease Trial, Shares Tumble

Reuters
·
Jul 09

Kalaris Appoints Laurie Keating to Board, Replacing Morana Jovan-embiricos

Reuters
·
Jul 07

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-07-02

Reuters
·
Jul 02

Movement Alert|Alnylam Pharmaceuticals Rises 5.01% in Regular Trading, Multiple Partnership Catalysts Fuel Rally Amid Biotech Sector Strength

Market Focus
·
Jul 02

Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Biohaven Ltd. (BHVN) and Praxis Precision Medicines (PRAX)

TIPRANKS
·
Jun 29

Alnylam Pharmaceuticals is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jun 29

Alnylam Pharmaceuticals, Inc. : H.c. Wainwright Cuts Target Price to $470 from $510

THOMSON REUTERS
·
Jun 29

Alnylam price target lowered to $470 from $510 at H.C. Wainwright

TIPRANKS
·
Jun 29

Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Cytokinetics (CYTK)

TIPRANKS
·
Jun 29

Alnylam Pharma (ALNY) Receives a Buy from Barclays

TIPRANKS
·
Jun 29